comparemela.com

Latest Breaking News On - Derek cole - Page 15 : comparemela.com

Dynavax to Present at the Cowen 43rd Annual Health Care Conference

/PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative.

United-kingdom
Great-britain
Derek-cole
Kelly-macdonald
Nicole-arndt
Health-care-conference-on
Twitter
European-union
Investor-relations-advisory-solutions
Dynavax-technologies-corporation-nasdaq
Dynavax-technologies-corporation
Chief-financial-officer

Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance

2022 total revenue of $723 million, up 64% from $439 million in 2021 HEPLISAV-B® vaccine net product revenue of $126 million, representing 104% growth compared.

Derek-cole
Ryan-spencer
Nicole-arndt
Centers-for-disease
Prevention-advisory-committee-of-immunization-practices
Delivery-networks-idns
Dynavax-technologies-corporation-nasdaq
Exchange-commission
Development-expenses
Corporate-communications
European-union

Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance

Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Derek-cole
Ryan-spencer
Nicole-arndt
Centers-for-disease
Prevention-advisory-committee-of-immunization-practices
Delivery-networks-idns
Presidentinvestor-relations-advisory-solutions
Exchange-commission
Development-expenses
Prnewswire-dynavax-technologies-corporation-nasdaq
European-union

Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023

/PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative.

Derek-cole
Nicole-arndt
Prnewswire-dynavax-technologies-corporation-nasdaq
European-union
Corporate-communications
Investor-relations-advisory-solutions
Technologies-corporation
Dynavax-technologies

Dynavax Announces Uplisting to the Nasdaq Global Select Market

/PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company focused on developing and commercializing.

Derek-cole
Ryan-spencer
Nicole-arndt
Exchange-commission
Linkedin
European-union
Investor-relations-advisory-solutions
Nasdaq
Dynavax-technologies-corporation-nasdaq
Technologies-corporation
Nasdaq-global-select-market
Chief-executive-officer

vimarsana © 2020. All Rights Reserved.